Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2025 Earnings Call Transcript November 3, 2025
Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.94 EPS, expectations were $-0.82.
Operator: Good morning, and welcome to the Axsome Therapeutics Third Quarter 2025 Earnings Conference Call. My name is Daryl, and I will be your operator for today’s call. [Operator Instructions] Please note that this call is being recorded. I would now like to hand the call over to Darren...
